Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

57.75

+0.31 (0.54%)

At close: Feb 21, 2025, 4:00 PM

56.89

-0.86 (-1.49%)

After-hours: Feb 21, 2025, 6:32 PM EST

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $7.11 billion as of February 21, 2025. Its market cap has increased by 53.74% in one year.

Market Cap

7.11B

Enterprise Value

8.05B

1-Year Change

53.74%

Ranking

#1077

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $7.11B, an increase of 87,703.53%. That is a compound annual growth rate of 38.20%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	7.11B	16.92%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.21B
UnitedHealth Group	462.37B
Johnson & Johnson	384.45B
Novo Nordisk	370.84B
AbbVie	354.62B
Abbott Laboratories	230.98B
AstraZeneca	227.07B
Merck & Co.	221.80B

Market Cap Rankings